U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...

State workers’ access to weight loss drugs has put House Speaker Tim Moore at odds with State Treasurer Dale Folwell, who ran ...

The company is expected to present critical results from a trial of its CagriSema weight-loss injection in the fourth quarter ...

A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.

Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is ...

Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is for type 2 diabetes, have become synonymous with weight loss fads. Here’s ...

Medicare covers Wegovy as a treatment to reduce the risk of serious cardiovascular events in people who have overweight or obesity. It does not cover Wegovy for weight loss.

Medicare covers Wegovy only as a treatment to reduce the risk of heart attacks and strokes in people who have overweight or obesity. It does not cover Wegovy for weight loss. Medicare is currently ...

Originally approved to help with excess weight and obesity, Wegovy and Ozempic, have become synonymous with weight loss fads.

Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is for type 2 diabetes, have become synonymous with weight loss fads.